Targeted IL-24 gene therapy inhibits cancer recurrence after liver tumor resection by inducing tumor cell apoptosis in nude mice

Hepatobiliary and Pancreatic Diseases International

Volumn 8, Issue 2, 2009, Pages 174-178

  Yang, Yong Jiu ^a,b   Chen, Da Zhi ^a   Li, Li Xin ^a   Sheng, Qin Song ^a   Jin, Zhong Kui ^a   Zhao, De Fang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING CHUIYANGLIU HOSPITAL   (China)

Author keywords

Apoptosis; Gene therapy; Interleukin 24; Liver neoplasms

Indexed keywords

ADENOVIRUS VECTOR; ALPHA FETOPROTEIN; INTERLEUKIN 24;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; LIVER CELL CARCINOMA; MALE; MOUSE; NICK END LABELING; NONHUMAN; PARTIAL HEPATECTOMY; RADIOIMMUNOASSAY; RECURRENT CANCER; VIRAL GENE DELIVERY SYSTEM;

ALPHA-FETOPROTEINS; ANIMALS; APOPTOSIS; DEPENDOVIRUS; GENE THERAPY; HEPATECTOMY; IN SITU NICK-END LABELING; INTERLEUKINS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM RECURRENCE, LOCAL; PROMOTER REGIONS, GENETIC;

EID: 64949194262     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Capocaccia R, Sant M, Berrino F, Simonetti A, Santi V, Trevisani F, et al. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am J Gastroenterol 2007;102: 1661-1671.
2. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127:S5-S16.
3. Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, et al. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery 2007;141:330-339.
4. Chen WT, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, et al. Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome. Eur J Surg Oncol 2004;30:414-420.
5. Taura K, Ikai I, Hatano E, Fujii H, Uyama N, Shimahara Y. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg 2006;244:265-273.
6. Li PC, Li Y, Tang ZY, Wang L, Lu R, Xue Q. Study on the inhibitory effect of tyroserleutide on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis. Hepatogastroenterology 2007;54: 1359-1363.
7. Yan J, Zheng Q, Wang Y, Lu HF, Xue Q, Tang ZY. Vasoinhibitory effect of daltepartin sodium on human hepatocellular carcinoma in nude mice. Zhonghua Gan Zang Bing Za Zhi 2005;13:359-361.
8. Li Y, Tian B, Yang J, Zhao L, Wu X, Ye SL, et al. Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics. J Cancer Res Clin Oncol 2004; 130:460-468.
9. Yang R, Rescorla FJ, Reilly CR, Faught PR, Sanghvi NT, Lumeng L, et al. A reproducible rat liver cancer model for experimental therapy: introducing a technique of intrahepatic tumor implantation. J Surg Res 1992;52:193-198.
10. Lebedeva IV, Sauane M, Gopalkrishnan RV, Sarkar D, Su ZZ, Gupta P, et al. mda-7/IL-24: exploiting cancer's Achilles' heel. Mol Ther 2005;11:4-18.
11. Emdad L, Lebedeva IV, Su ZZ, Gupta P, Sarkar D, Settleman J, et al. Combinatorial treatment of non-small-cell lung cancers with gefitinib and Ad.mda-7 enhances apoptosis-induction and reverses resistance to a single therapy. J Cell Physiol 2007;210:549-559.
12. Zheng M, Bocangel D, Doneske B, Mhashilkar A, Ramesh R, Hunt KK, et al. Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10. Cancer Immunol Immunother 2007;56:205-215.
13. Lebedeva IV, Su ZZ, Sarkar D, Gopalkrishnan RV, Waxman S, Yacoub A, et al. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis. Oncogene 2005;24:585-596.
14. Saito Y, Miyahara R, Gopalan B, Litvak A, Inoue S, Shanker M, et al. Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated -7 (mda-7)/interieukin-24 (IL-24) gene. Cancer Gene Ther 2005;12:238-247.
15. Chen WY, Cheng YT, Lei HY, Chang CP, Wang CW, Chang MS. IL-24 inhibits the growth of hepatoma cells in vivo. Genes Immun 2005;6:493-499.
16. Wang X, Ye Z, Zhong J, Xiang J, Yang J. Adenovirus-mediated IL-24 expression suppresses hepatocellular carcinoma growth via induction of cell apoptosis and cycling arrest and reduction of angiogenesis. Cancer Biother Radiopharm 2007;22:56-63.
17. Su Z, Emdad L, Sauane M, Lebedeva IV, Sarkar D, Gupta P, et al. Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells. Oncogene 2005;24:7552-7566.
18. Gupta P, Su ZZ, Lebedeva IV, Sarkar D, Sauane M, Emdad L, et al. mda-7/ IL-24: multifunctional cancer-specific apoptosis-inducing cytokine. Pharmacol Ther 2006;111: 596-628.
19. Ishikawa S, Nakagawa T, Miyahara R, Kawano Y, Takenaka K, Yanagihara K, et al. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer. Clin Cancer Res 2005;11:1198-1202.
20. Fisher PB, Gopalkrishnan RV, Chada S, Ramesh R, Grimm EA, Rosenfeld MR, et al. mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic. Cancer Biol Ther 2003;2:S23-37.
21. Ramesh R, Mhashilkar AM, Tanaka F, Saito Y, Branch CD, Sieger K, et al. Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. Cancer Res 2003;63: 5105-5113.
22. Sauane M, Lebedeva IV, Su ZZ, Choo HT, Randolph A, Valerie K, et al. Melanoma differentiation associated gene-7/interleukin-24 promotes tumor cell-specific apoptosis through both secretory and nonsecretory pathways. Cancer Res 2004;64:2988-2993.